Summary Primatene Mist inhalers provide temporary relief from mild, intermittent asthma symptoms. They are the only OTC ...

If currently taking a prescription monoamine oxidase inhibitor (MAOI) (eg, certain drugs taken for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after ...

Amphastar's Q2 2024 revenue grew 25% year-over-year to $182.4 million, primarily driven by BAQSIMI and Primatene MIST sales. Primatene MIST faces future challenges as its key patent expires in ...

2 Misting Modes: You can set the deffusor to intermittent mist (6-8 hrs working time) that diffuser mists and pauses every 30s, it goes for almost the whole night; Or set it to continuous mist (3 ...

This portable nebulizer machine carrying case, inhaler holder external dimensions: 8.67 x 4.67 x 2.81 inches, internal dimensions: 7.9 x 3.95 x 2.11 inches.(L x W x H). perfectly fit portable ...

A key highlight for the quarter was Primatene MIST which achieved its highest quarterly sales since the launch reaching $26 million in sales. This performance is a significant step toward our goal ...

Our strategic initiatives regarding our regulatory filings and commercial portfolio execution remain on track and we are well positioned to continue the growth of our key revenue drivers with BAQSIMI, ...

We are building upon our strong heritage in bronchodilator and inhaler development with ongoing clinical development programmes aimed at improving the outlook for people with COPD. COPD is a ...

Dry-powder inhalers – which a patient uses by sucking in a powdered medicine – and soft mist inhalers, which have a cartridge that releases a mist that is inhaled, have a far lower climate toll.